跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Panvax H5N8 pre-pandemic, Pre-pandemic influenza vaccine (split-virion, inactivated) 10 mL multi-dose injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
Panvax H5N8 pre-pandemic, Pre-pandemic influenza vaccine (split-virion, inactivated) 10 mL multi-dose injection vial
Approved
STANDARD
Panvax H5N8 pre-pandemic, Pre-pandemic influenza vaccine (split-virion, inactivated) 10 mL multi-dose injection vial
Seqirus Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
ccfe74547ce39c71
Company
Seqirus Pty Ltd
Type
Standard
Approval Details
Approval Id
ccfe74547ce39c71
Product Name
Panvax H5N8 pre-pandemic, Pre-pandemic influenza vaccine (split-virion, inactivated) 10 mL multi-dose injection vial
Artg Id
421511
Artg Name
Panvax H5N8 pre-pandemic, Pre-pandemic influenza vaccine (split-virion, inactivated) 10 mL multi-dose injection vial
Sponsor
Seqirus Pty Ltd
Company Detail Path
/organization/seqirus-pty-ltd
Artg Date
2023-10-06
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/b5be7f6f58a94c5cab6e16b4018f032a.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/48ec0eab5796d00bb16559fdb2a4d63e.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
ccfe74547ce39c71
Type
Standard
Back to TGA Approvals